Danielle Antalffy

Lilia-Celine Lozada

Richard Newitter

Ryan Zimmerman

Aaron Wukmir

Benjamin Haynor

Felipe Lamar

Jayna Renee Francis

Kallum Titchmarsh

Rick Wise

Robert Marcus

- Treace Medical Concepts aims to **double its business** by increasing market penetration from **3%** to **7-8%** of symptomatic bunion surgical candidates, leveraging its established commercial team and customer base.  **[1630627_tx_379963_0]** 
- In Q3 2025, the company is launching three new systems: **Nanoplasty**, **Percutoplasty** (3D MIS osteotomy systems), and the **SpeedMTP Rapid Compression Implant system**, expanding its comprehensive bunion solutions portfolio.  **[1630627_tx_379963_1]** 
- The company is focused on advancing minimally invasive surgery (MIS) and leveraging platform technologies like **SpeedPlate Rapid Compression Implants** and **IntelliGuide PSI** to offer more effective solutions and broaden surgeon appeal.  **[1630627_tx_379963_1]** **[1630627_tx_379963_4]** **[1630627_tx_379963_5]** **[1630627_tx_379963_11]** **[1630627_tx_379963_20]** **[1630627_tx_379963_22]**

Treace Medical Concepts Outlines Growth Strategy and New Product Launches at 2025 Investor Day

TREACE MEDICAL CONCEPTS (TMCI)